Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Apr 15:6:173-82.
doi: 10.2147/tcrm.s6717.

Ropinirole in restless legs syndrome and periodic limb movement disorder

Daniel Erichsen  1 , Raffaelle Ferri, David Gozal
Affiliations

Ropinirole in restless legs syndrome and periodic limb movement disorder

Daniel Erichsen et al. Ther Clin Risk Manag. .

Abstract

Restless legs syndrome and periodic limb movement disorder of sleep are now recognized as prevalent, distinct, yet overlapping disorders affecting all age groups. Although delineation of the mechanisms underlying these disorders continues to be the focus of very intense research efforts, it has become apparent that there is a prominent role for dopaminergic agents in the clinical management of these patients. Among the various dopaminergic drugs, ropinirole has undergone relatively intense and critical scrutiny, and appears to provide a safe and efficacious treatment option for patients with these two conditions. The more recent development of a controlled formulation for this drug is likely to yield additional benefits such as improved adherence and reduced fluctuations in daytime and nighttime symptoms. However, there is not enough evidence at this time to support such assumption.

Keywords: dopaminergic drugs; period limb movement disorder; restless legs syndrome; ropinirole.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Allen AP, Earley CJ. Restless legs syndrome: A review of clinical and pathophysiologic features. J Clin Neurophysiol. 2001;18:128–147. - PubMed
    1. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology A report from restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med. 2003;4:101–119. - PubMed
    1. Trenkwalder C, Hogl B, Winkelmann J. Recent advances in the diagnosis, genetics and treatment of resltess legs syndrome. J Neurol. 2009;256:539–553. - PubMed
    1. Simakajornboon HN, Kheirandish-Gozal L, Gozal D. Diagnosis and management of restless legs syndrome in children. Sleep Med Rev. 2009;13:149–156. - PMC - PubMed
    1. McRae A. Neurotransmitters and pharmacology of the basal ganglia. In: Jankovic J, Tolosa E, editors. Parkinson’s Disease and Movement Disorders. Baltimore: Williams and Wilkins; 1998. pp. 491–592.